TrialJournal of the American Society of Nephrology : JASN2010
Avosentan for overt diabetic nephropathy.
Johannes F E Mann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
221 papers cite itlatest 60 shown
this paperpooled ittrialcites it